Delivery Order SPE2DB22D3011-SPE2DB25FP7JD
Award Date
10/18/24
Potential Completion Date
10/21/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ozempic, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 22, 2024, with a ceiling value of $1,084.03 and a completion date of November 25, 2024. This is a delivery order contract, with a firm fixed price pricing type. The contract is not designated with a set-aside...
This federal contract award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty medication used for diabetes management. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 17, 2024 with a completion date of October 18, 2024. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,062.97. This award is a part of AmerisourceBergen's larger Indefinite Delivery...
This federal contract award is for the delivery of Ozempic, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $6,487.57, has a completion date of December 14, 2023 and is a firm fixed-price delivery order. This award is part of a larger...
This federal contract award is for the delivery of Ozempic, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $10,055.07, and has an ultimate completion date of March 19, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the pharmaceutical product Ozempic, a diabetes medication, valued at $15,301.23. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 28, 2025. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Ozempic, a medication used for the treatment of diabetes, to support military healthcare programs. The contract, valued at $2,612.36, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award, valued at $27,886.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic, a medication used to treat type 2 diabetes, with an ultimate completion date of December 24, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,948.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic, a medication used to treat type 2 diabetes, and has an ultimate completion date of September 11, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ozempic, a medication used to treat type 2 diabetes, with a ceiling value of $6,266.60. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. This contract award is not associated with a set-aside program and is part of a larger Indefinite...
This federal contract award is for the delivery of Ozempic medication to the Defense Logistics Agency (DLA), which is a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $3,133.30. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 17, 2024. This award is associated with a larger Indefinite Delivery Contract...